#dc#dc comics#batman#bruce wayne#dick grayson#batfamily#batfam#dc fanart#tim drake
seen from United Arab Emirates
seen from Türkiye
seen from United Kingdom
seen from Philippines
seen from United States
seen from Malaysia
seen from Hong Kong SAR China
seen from Germany
seen from Malaysia
seen from United States
seen from Russia
seen from T1
seen from India
seen from United States
seen from Sweden
seen from United States
seen from United Kingdom
seen from China
seen from United States
seen from Germany
For our Saturday edition of The Daily Dive, host Cassandra Leah sits down with that of JR Rhan, founder and co-CEO of Mind Medicine (NEO: MMED). JR joins us to discuss operating in
For our Saturday edition of The Daily Dive, host Cassandra Leah sits down with that of JR Rhan, founder and co-CEO of Mind Medicine (NEO: MMED). JR joins us to discuss operating in
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
MindMed Plans to Use the Phase 1 Study to Experiment with Dosing Methods to Better Understand How Humans React to Ayahuasca’s Active Ingredient, DMT The Phase 1 Clinical Trials Will Put MindMed in a Position to Potentially Progress to Phase 2A Proof of Concept Trials Down the Road Psychedelics pharma leader MindMed (NEO: MMED) (OTCQB: MMEDF) (FRA: BGHM) announced Thursday the company is gearing up to begin a new Phase 1 clinical trial in conjunction with the Swiss-based Liechti Lab at the University Hospital Basel. The study, expected to begin in Q4 of 2020, will focus on the psychedelic substance DMT and its effect on humans. MindMed, which is backed by Shark Tank billionaire Kevin O’Leary and Canopy Growth (TSX: WEED) (NYSE: CGC) (FRA: 11L1) founder Bruce Linton will provide the startup funding for the Phase 1 clinical trial intended to test various intravenous DMT dosing procedures. N,N-Dimethyltryptamine, aka DMT, is a well-known and naturally-occurring psychedelic substance and is the main ingredient in the psychoactive brew Ayahuasca. Compared to similar psychedelics like LSD and Psilocybin (Magic Mushrooms), DMT has a rapid onset and offset action with its hallucinogenic effects lasting on average for around 30 minutes. Traditionally, Ayahuasca has used …
Psychedelics: Cures, Charlatans & MindMed (MMED)
The first episode of the Grizzle Psychedelics series examines the potential of psychedelics to treat addiction & depression and the recent MindMed (MMED) listing. #psychedelics #addiction Read the full article
